These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 22482449)

  • 1. Alzheimer's disease and the amyloid β-protein.
    Walsh DM; Teplow DB
    Prog Mol Biol Transl Sci; 2012; 107():101-24. PubMed ID: 22482449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β: the seeds of darkness.
    Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease.
    Schonrock N; Matamales M; Ittner LM; Götz J
    Exp Neurol; 2012 Jun; 235(2):447-54. PubMed ID: 22119426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.
    Farzan M; Schnitzler CE; Vasilieva N; Leung D; Choe H
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9712-7. PubMed ID: 10931940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of the amyloid β and/or of β-amyloid precursor protein of the fetus with trisomy 21 to the maternal blood stream and its possible contribution to the pathogenesis of the maternal Alzheimer's Disease.
    Mohamad López H
    Med Hypotheses; 2011 Dec; 77(6):1058-61. PubMed ID: 21944886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alzheimer's disease, amyloid peptide and synaptic dysfunction].
    Hémar A; Mulle C
    Med Sci (Paris); 2011; 27(8-9):733-6. PubMed ID: 21880261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological characteristics of amyloid precursor protein and Alzheimer's disease].
    Fukatsu R; Tsuzuki K; Takamaru Y; Hayashi Y; Sasaki N; Yoshida T; Midorikawa Y; Fujii N; Takahata N
    Rinsho Byori; 1996 Mar; 44(3):213-24. PubMed ID: 8857163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.
    Hamley IW
    Chem Rev; 2012 Oct; 112(10):5147-92. PubMed ID: 22813427
    [No Abstract]   [Full Text] [Related]  

  • 14. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.
    Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T
    FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease.
    Porzoor A; Macreadie IG
    J Alzheimers Dis; 2013; 35(2):217-25. PubMed ID: 23396350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimer's disease.
    Wagner SL; Munoz B
    J Clin Invest; 1999 Nov; 104(10):1329-32. PubMed ID: 10562291
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the mechanism of the DNA nicking property of amyloid-β40: implications in Alzheimer's disease.
    Gupta VB; Monica FS; Berrocal R; Rao KS; Rao KS
    J Alzheimers Dis; 2013; 33(4):1059-71. PubMed ID: 23160010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Compensatory function of transthyretin in Alzheimer's disease].
    Shwartsman AL; Sarantseva SV
    Tsitologiia; 2011; 53(10):772-7. PubMed ID: 22232933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.